美股异动 | 美敦力(MDT.US)盘前涨4% 二季度业绩超预期

Core Viewpoint - Medtronic (MDT.US) reported a strong performance in its Q2 FY2026 results, exceeding analyst expectations in both earnings and revenue [1] Financial Performance - Non-GAAP earnings per share for Q2 FY2026 were $1.36, up from $1.26 a year ago, and above the analyst estimate of $1.31 [1] - Quarterly net sales reached $8.96 billion, compared to $8.4 billion in the same quarter last year, surpassing the expected $8.87 billion [1] Future Guidance - For FY2026, the company raised its non-GAAP earnings per share guidance to a range of $5.62 to $5.66, up from the previous guidance of $5.60 to $5.66, aligning with analyst expectations of $5.62 [1] - Medtronic also increased its revenue growth forecast for FY2026 from 5% to 5.5%, which includes an estimated $185 million potential tariff impact [1]